Rate-limiting factors of cholesterol efflux in reverse cholesterol transport: Acceptors and donors

被引:10
|
作者
Fu, Ying [1 ]
机构
[1] Baker Heart & Diabet Inst, Melbourne, Vic 8008, Australia
关键词
ATP-binding cassette transporters; cholesteryl ester; high-density lipoprotein; lecithin:cholesterol acyltransferase; liver X receptor; macrophage; reverse cholesterol transport; scavenger receptor BI; HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; BINDING CASSETTE TRANSPORTERS; SCAVENGER RECEPTOR BI; APOA-I; CELLULAR CHOLESTEROL; SR-BI; HARLEQUIN ICHTHYOSIS; HDL CHOLESTEROL; INCREASED ATHEROSCLEROSIS;
D O I
10.1111/j.1440-1681.2010.05386.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P>1. Plasma levels of high-density lipoprotein (HDL) are believed to be inversely related to coronary artery disease. High-density lipoprotein plays a key role in the process of reverse cholesterol transport, by which HDL is able to extract excess cholesterol from peripheral tissues and transfer it to the liver for biliary excretion. 2. Efflux of lipids (cholesterol and phospholipids) is the first step in reverse cholesterol transport. Several cellular membrane transporters, including ABCA1 and ABCG1, as well as scavenger receptor (SR)-BI receptor, are believed to facilitate the active efflux of cholesterol to lipid-poor apolipoprotein A-I and mature HDL, respectively. Furthermore, overexpression or deletion of one or more specific genes supports the view that HDL is involved in cholesterol efflux. 3. In conclusion, current evidence supports a critical role for HDL in atheroprotection via an active efflux pathway through reverse cholesterol transport, with the substantial support of appropriate functions of cell donors.
引用
收藏
页码:703 / 709
页数:7
相关论文
共 50 条
  • [41] Reverse cholesterol transport revisited
    Astrid E van der Velde
    [J]. World Journal of Gastroenterology, 2010, 16 (47) : 5907 - 5907
  • [42] An overview of reverse cholesterol transport
    Tall, AR
    [J]. EUROPEAN HEART JOURNAL, 1998, 19 : A31 - A35
  • [43] Acceleration of reverse cholesterol transport
    von Eckardstein, A
    Nofer, JR
    Assmann, G
    [J]. CURRENT OPINION IN CARDIOLOGY, 2000, 15 (05) : 348 - 354
  • [44] Tachometer for Reverse Cholesterol Transport?
    von Eckardstein, Arnold
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2012, 1 (04):
  • [45] RETHINKING REVERSE CHOLESTEROL TRANSPORT
    Pownall, Henry J.
    Gillard, Baiba K.
    Rosales, Corina
    Gotto, Antonio M.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 27 - 28
  • [46] Reverse cholesterol transport fluxes
    Hellerstein, Marc
    Turner, Scott
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2014, 25 (01) : 40 - 47
  • [47] Pathophysiology of reverse cholesterol transport
    Calabresi, L
    [J]. CHEMISTRY AND PHYSICS OF LIPIDS, 2005, 136 (02) : 89 - 90
  • [48] Overexpression and deletion of phospholipid transfer protein reduce HDL mass and cholesterol efflux capacity but not macrophage reverse cholesterol transport
    Kuwano, Takashi
    Bi, Xin
    Cipollari, Eleonora
    Yasuda, Tomoyuki
    Lagor, William R.
    Szapary, Hannah J.
    Tohyama, Junichiro
    Millar, John S.
    Billheimer, Jeffrey T.
    Lyssenko, Nicholas N.
    Rader, Daniel J.
    [J]. JOURNAL OF LIPID RESEARCH, 2017, 58 (04) : 731 - 741
  • [49] APOLIPOPROTEIN A-I-CONTAINING PARTICLES AND REVERSE CHOLESTEROL TRANSPORT - EVIDENCE FOR CONNECTION BETWEEN CHOLESTEROL EFFLUX AND ATHEROSCLEROSIS RISK
    FRUCHART, JC
    DEGETEIRE, C
    DELFLY, B
    CASTRO, GR
    [J]. ATHEROSCLEROSIS, 1994, 110 : S35 - S39
  • [50] A new framework for reverse cholesterol transport: Non-biliary contributions to reverse cholesterol transport
    Temel, Ryan E.
    Brown, J. Mark
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (47) : 5946 - 5952